Inventory, Net of BIO-RAD LABORATORIES, INC. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
BIO-RAD LABORATORIES, INC. quarterly Inventory, Net in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Inventory, Net for the quarter ending 31 Dec 2025 was $740,700,000, a 2.5% decline year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $740,700,000 -$19,300,000 -2.5% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $783,200,000 -$21,076,000 -2.6% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $798,800,000 -$4,893,000 -0.61% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $790,100,000 +$6,731,000 +0.86% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $760,000,000 -$20,500,000 -2.6% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $804,276,000 +$28,458,000 +3.7% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $803,693,000 +$27,093,000 +3.5% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $783,369,000 +$30,432,000 +4% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $780,500,000 +$61,184,000 +8.5% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $775,818,000 +$89,968,000 +13% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $776,600,000 +$119,470,000 +18% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $752,937,000 +$147,445,000 +24% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $719,316,000 +$147,077,000 +26% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $685,850,000 +$96,939,000 +16% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $657,130,000 +$58,141,000 +9.7% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $605,492,000 +$336,000 +0.06% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $572,239,000 -$50,014,000 -8% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $588,911,000 -$51,317,000 -8% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $598,989,000 -$29,412,000 -4.7% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $605,156,000 +$48,127,000 +8.6% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $622,253,000 +$68,246,000 +12% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $640,228,000 +$52,241,000 +8.9% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $628,401,000 +$38,504,000 +6.5% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $557,029,000 -$33,409,000 -5.7% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $554,007,000 -$29,808,000 -5.1% 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $587,987,000 -$13,066,000 -2.2% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $589,897,000 -$1,536,000 -0.26% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $590,438,000 -$21,779,000 -3.6% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $583,815,000 -$10,989,000 -1.8% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $601,053,000 -$518,000 -0.09% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $591,433,000 +$10,852,000 +1.9% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $612,217,000 +$52,398,000 +9.4% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $594,804,000 +$69,843,000 +13% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $601,571,000 +$45,213,000 +8.1% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $580,581,000 +$39,067,000 +7.2% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $559,819,000 +$26,507,000 +5% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $524,961,000 +$34,737,000 +7.1% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 $556,358,000 +$43,622,000 +8.5% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $541,514,000 +$40,539,000 +8.1% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 $533,312,000 +$54,937,000 +11% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 $490,224,000 +$19,227,000 +4.1% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $512,736,000 -$3,311,000 -0.64% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $500,975,000 -$19,667,000 -3.8% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $478,375,000 -$35,477,000 -6.9% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $470,997,000 -$45,248,000 -8.8% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $516,047,000 -$7,456,000 -1.4% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $520,642,000 +$35,975,000 +7.4% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 $513,852,000 +$46,531,000 +10% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $516,245,000 +$61,125,000 +13% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $523,503,000 +$65,075,000 +14% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $484,667,000 +$35,210,000 +7.8% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $467,321,000 +$3,952,000 +0.85% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $455,120,000 +$21,610,000 +5% 31 Dec 2012 10-K 18 Mar 2014 2013 FY
Q3 2012 $458,428,000 +$12,847,000 +2.9% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $449,457,000 +$120,000 +0.03% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $463,369,000 +$33,394,000 +7.8% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $433,510,000 +$35,410,000 +8.9% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 $445,581,000 +$42,698,000 +11% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 $449,337,000 +$79,065,000 +21% 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 $429,975,000 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 $398,100,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
Q3 2010 $402,883,000 30 Sep 2010 10-Q 09 Nov 2010 2010 Q3
Q2 2010 $370,272,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.